0002080322-25-000008.txt : 20250814 0002080322-25-000008.hdr.sgml : 20250814 20250813184429 ACCESSION NUMBER: 0002080322-25-000008 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20250814 DATE AS OF CHANGE: 20250813 EFFECTIVENESS DATE: 20250814 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SRT Therapeutics, Inc. CENTRAL INDEX KEY: 0002080322 ORGANIZATION NAME: EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-554665 FILM NUMBER: 251213492 BUSINESS ADDRESS: STREET 1: 5601 OBERLIN DRIVE STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: (858) 868-7108 MAIL ADDRESS: STREET 1: 5601 OBERLIN DRIVE STREET 2: SUITE 100 CITY: SAN DIEGO STATE: CA ZIP: 92121 D 1 primary_doc.xml X0708 D LIVE 0002080322 SRT Therapeutics, Inc. 5601 Oberlin Drive, Suite 100 San Diego CA CALIFORNIA 92121 (858) 868-7108 DELAWARE None None Corporation true 2024 Lauren Otsuki 5601 Oberlin Drive, Suite 100 San Diego CA CALIFORNIA 92121 Executive Officer Director Ed Prunchunas 5601 Oberlin Drive, Suite 100 San Diego CA CALIFORNIA 92121 Director Shierley Widjaja 5601 Oberlin Drive, Suite 100 San Diego CA CALIFORNIA 92121 Director Michael Walsh 5601 Oberlin Drive, Suite 100 San Diego CA CALIFORNIA 92121 Director Rolf Benirschke 5601 Oberlin Drive, Suite 100 San Diego CA CALIFORNIA 92121 Director Brian G. Feagan, M.D. 5601 Oberlin Drive, Suite 100 San Diego CA CALIFORNIA 92121 Director Biotechnology Decline to Disclose 06b false 2025-04-04 false true false 0 47510731 47399588 111143 false 55 0 0 0 false SRT Therapeutics, Inc. /s/ Lauren Otsuki Lauren Otsuki President and Chief Executive Officer 2025-08-13